search icon
  • Print
  • ShareThis
  • Text Size
  • HIVMA and IDSA Comment on CDC’s Proposed Updated Organ Transplantation Guidelines

    HIVMA and IDSA filed joint public comments in response to the CDC’s proposed PHS Guideline for Reducing Transmission of Human Immunodeficiency Virus (HIV), Hepatitis B Virus (HBV), And Hepatitis C Virus (HCV)Through Solid Organ Transplantation.

    The draft guidelines update the 1994 organ transplantation recommendations and suggest areas for further research to address the knowledge gaps in HIV, HBV and HCV transmission prevention, detection, and management. The major changes to the guideline are:

    • Addition of HBV and HCV, in addition to HIV.
    • Utilizing the factors known to be associated with increased likelihood of recent HIV, HBV or HCV to identify potential donors at increased risk for transmitting infection versus exclusionary criteria for donation.
    • Focusing on solid organs from deceased and living donors since the Food and Drug Administration 13 has since implemented more comprehensive regulations of tissues and semen donors.
    • Distinguishing between expected and unexpected transmission of HBV and HCV.

    The HIVMA-IDSA comments support the document’s inclusion of the need for further research on the “risk-benefit of transplanting organs from HIV-infected donors into HIV-infected recipients, given the need for transplants in HIV-infected recipients and improved outcomes with the availability of highly active anti-retroviral therapy (HAART).”  The comments also urge a more balanced approach to risk assessment to avoid reducing transplantations while having little impact on safety, and urge clarification and consistency with regard to MSM donor risk.

    Read the full comments  PDF

| IDSA | Contact Us

© Copyright HIVMA 2018 HIV Medicine Association

Full Site Mobile Site